Evidence and Guidance Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda), are increasingly prescribed for type 2 diabetes and weight management
We know there are countless weight loss options and a different diet craze or miracle food seemingly every other day, and we know how confusing that can all be
Among these, the incretin Glucagon-Like Peptide-1 (GLP-1), which is synthetized as proglucagon precursor peptide, then cleaved and secreted by L-cells disseminated in a proximal to distal gradient in the gut epithelium 1 , exerts insulinotropic actions and controls glucose metabolism by binding to the GLP-1 receptors (GLP-1R) highly expressed on pancreatic beta cells 2
A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood
Switching from semaglutide to tirzepatide provides receptor novelty through GIP receptor activation while maintaining continuous appetite suppression